| RS863224053 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS863224054 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS863224055 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS863224057 |
LRPPRC
|
Health Risk |
Likely pathogenic |
— |
| RS863224058 |
LRPPRC
|
Health Risk |
Likely pathogenic |
— |
| RS863224059 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS863224064 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Retinal dystrophy |
| RS863224065 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS863224066 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary motor and sensory neuropathy with optic atrophy, Charcot-Marie-Tooth disease type 2 |
| RS863224068 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS863224069 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cerebellar ataxia |
| RS863224072 |
MPV17
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Charcot-Marie-Tooth disease |
| RS863224074 |
MPV17
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS863224075 |
MRPS16
|
Health Risk |
Pathogenic |
— |
| RS863224077 |
MRPS22
|
Health Risk |
Pathogenic |
— |
| RS863224079 |
NDUFA11
|
Health Risk |
Pathogenic |
— |
| RS863224083 |
NDUFA10
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS863224084 |
NDUFA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic Leukoencephalopathy, Mitochondrial complex I deficiency |
| RS863224089 |
NDUFAF1
|
Health Risk |
Pathogenic |
— |
| RS863224097 |
NDUFS1
|
Health Risk |
Likely pathogenic |
— |
| RS863224099 |
NDUFS1
|
Health Risk |
Likely pathogenic |
— |
| RS863224100 |
NDUFS1
|
Health Risk |
Likely pathogenic |
— |
| RS863224101 |
NDUFS1
|
Health Risk |
Likely pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS863224103 |
NDUFS1
|
Health Risk |
Likely pathogenic |
— |
| RS863224106 |
NDUFS3
|
Health Risk |
Likely pathogenic |
— |
| RS863224107 |
NDUFS3
|
Health Risk |
Pathogenic |
— |
| RS863224110 |
NDUFS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 9 |
| RS863224111 |
NDUFS6
|
Health Risk |
Likely pathogenic |
— |
| RS863224113 |
NDUFS7
|
Health Risk |
Pathogenic |
— |
| RS863224115 |
NDUFS8
|
Health Risk |
Likely pathogenic |
— |
| RS863224116 |
NDUFV1
|
Health Risk |
Likely pathogenic |
— |
| RS863224118 |
NDUFV1
|
Health Risk |
Pathogenic |
— |
| RS863224119 |
NDUFV1
|
Health Risk |
Pathogenic |
— |
| RS863224120 |
NDUFV1
|
Health Risk |
Pathogenic |
— |
| RS863224123 |
NUBPL
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 21 |
| RS863224127 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS863224128 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS863224130 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS863224131 |
OPA1
|
Health Risk |
Likely pathogenic |
Optic atrophy, Optic atrophy |
| RS863224132 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS863224134 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS863224135 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS863224136 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS863224137 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224140 |
OPA1
|
Health Risk |
Likely pathogenic |
9 conditions, Optic atrophy with or without deafness |
| RS863224141 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS863224142 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS863224143 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS863224145 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS863224146 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase complex deficiency |
| RS863224147 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, SUDDEN INFANT DEATH SYNDROME |
| RS863224148 |
PDHA1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Pyruvate dehydrogenase E1-alpha deficiency |
| RS863224149 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS863224150 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase complex deficiency |
| RS863224151 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS863224153 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS863224155 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS863224156 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Inborn genetic diseases |
| RS863224157 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS863224158 |
PDHB
|
Health Risk |
Likely pathogenic |
— |
| RS863224162 |
PDSS1
|
Health Risk |
Likely pathogenic |
— |
| RS863224163 |
PDSS1
|
Health Risk |
Pathogenic |
— |
| RS863224166 |
PDSS2
|
Health Risk |
Pathogenic |
— |
| RS863224167 |
PDSS2
|
Health Risk |
Likely pathogenic |
— |
| RS863224169 |
PNPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224174 |
PUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS863224176 |
PUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224178 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224180 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224182 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS863224183 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, RARS2-related disorder |
| RS863224186 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS863224191 |
RRM2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Rod-cone dystrophy, sensorineural deafness |
| RS863224192 |
RRM2B
|
Health Risk |
Pathogenic |
— |
| RS863224193 |
RRM2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe lactic acidosis, Mitochondrial DNA depletion syndrome 8a |
| RS863224194 |
RRM2B
|
Health Risk |
Pathogenic |
— |
| RS863224195 |
SARS2
|
Health Risk |
Pathogenic |
— |
| RS863224203 |
SLC19A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS863224204 |
SLC19A3
|
Health Risk |
Pathogenic |
— |
| RS863224208 |
SLC25A4
|
Health Risk |
Likely pathogenic |
— |
| RS863224209 |
SLC25A4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive |
| RS863224211 |
SLC37A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS863224216 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS863224223 |
SPG7
|
Health Risk |
Pathogenic |
— |
| RS863224224 |
SURF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Inborn genetic diseases |
| RS863224227 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS863224228 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS863224229 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS863224230 |
SURF1
|
Health Risk |
Likely pathogenic |
— |
| RS863224234 |
TIMM8A
|
Health Risk |
Likely pathogenic |
— |
| RS863224237 |
TPK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency, Childhood encephalopathy due to thiamine pyrophosphokinase deficiency |
| RS863224238 |
TPK1
|
Health Risk |
Pathogenic |
— |
| RS863224239 |
TRMU
|
Health Risk |
Likely pathogenic |
— |
| RS863224241 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, TRMU-related disorder |
| RS863224242 |
TRMU
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Aminoglycoside-induced deafness |
| RS863224246 |
TUFM
|
Health Risk |
Likely pathogenic |
— |
| RS863224247 |
TYMP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224248 |
TYMP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224250 |
TYMP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224251 |
TYMP
|
Health Risk |
Likely pathogenic |
— |